Pfizer Inc (PFE)
28.09
-0.21
(-0.74%)
USD |
NYSE |
Nov 01, 16:00
28.10
+0.01
(+0.04%)
After-Hours: 20:00
Pfizer Market Cap: 159.18B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 159.18B |
| October 31, 2024 | 160.37B |
| October 30, 2024 | 161.61B |
| October 29, 2024 | 161.27B |
| October 28, 2024 | 163.54B |
| October 25, 2024 | 161.22B |
| October 24, 2024 | 162.29B |
| October 23, 2024 | 163.54B |
| October 22, 2024 | 163.43B |
| October 21, 2024 | 163.94B |
| October 18, 2024 | 165.58B |
| October 17, 2024 | 165.86B |
| October 16, 2024 | 168.13B |
| October 15, 2024 | 166.83B |
| October 14, 2024 | 164.79B |
| October 11, 2024 | 165.24B |
| October 10, 2024 | 166.26B |
| October 09, 2024 | 171.08B |
| October 08, 2024 | 165.35B |
| October 07, 2024 | 165.47B |
| October 04, 2024 | 161.95B |
| October 03, 2024 | 160.59B |
| October 02, 2024 | 162.12B |
| October 01, 2024 | 162.46B |
| September 30, 2024 | 163.99B |
| Date | Value |
|---|---|
| September 27, 2024 | 164.84B |
| September 26, 2024 | 164.16B |
| September 25, 2024 | 163.94B |
| September 24, 2024 | 167.17B |
| September 23, 2024 | 166.09B |
| September 20, 2024 | 166.71B |
| September 19, 2024 | 168.07B |
| September 18, 2024 | 168.58B |
| September 17, 2024 | 169.04B |
| September 16, 2024 | 170.40B |
| September 13, 2024 | 165.86B |
| September 12, 2024 | 165.24B |
| September 11, 2024 | 168.07B |
| September 10, 2024 | 168.53B |
| September 09, 2024 | 166.66B |
| September 06, 2024 | 161.84B |
| September 05, 2024 | 161.56B |
| September 04, 2024 | 160.88B |
| September 03, 2024 | 160.37B |
| August 30, 2024 | 164.39B |
| August 29, 2024 | 162.75B |
| August 28, 2024 | 162.92B |
| August 27, 2024 | 163.31B |
| August 26, 2024 | 163.88B |
| August 23, 2024 | 163.77B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
143.15B
Minimum
Apr 25 2024
343.79B
Maximum
Dec 16 2021
216.72B
Average
204.71B
Median
Market Cap Benchmarks
| Amgen Inc | 171.59B |
| Johnson & Johnson | 385.53B |
| Eli Lilly and Co | 777.42B |
| Viking Therapeutics Inc | 8.121B |
| Moderna Inc | 21.00B |
Market Cap Related Metrics
| PE Ratio | 37.96 |
| PS Ratio | 2.657 |
| Price to Book Value | 1.815 |
| Price | 28.09 |
| Earnings Yield | 2.63% |
| Operating PE Ratio | 16.33 |
| Normalized PE Ratio | 18.10 |